NexImmune (NEXI)
OTHER OTC:NEXI

NexImmune (NEXI) Ownership - Who Owns NexImmune?

159 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 13, 2024
Kristi Jones
President & Ceo,director
xxxxxxxxxxxxx
<$0
Nov 22, 2023
xxxxxxxxxxxxx
$16024

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
635,934Institution46.38%852,152
356,571Institution26.01%477,805
50,000Institution3.65%67,000
36,999Institution2.70%49,579
17,304Institution1.26%23,187
14,792Institution1.08%19,821
12,010Institution0.88%16,093
8,043Institution0.59%10,778
5,009Institution0.37%6,712
4,186Institution0.31%5,609

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
356,571Institution26.01%477,805
50,000Institution3.65%67,000
17,304Institution1.26%23,187
14,792Institution1.08%19,821
8,043Institution0.59%10,778
5,009Institution0.37%6,712
4,186Institution0.31%5,609
1,155Institution0.08%1,548

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
12,010Institution0.88%33,268

FAQ

Who Owns NexImmune (NEXI)?
Currently, no data Available
What percentage of NexImmune (NEXI) stock is held by institutional investors?
Currently, no data Available
What percentage of NexImmune (NEXI) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of NexImmune (NEXI)?
Herbert Allen III owns the most shares of NexImmune (NEXI).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis